James Jobe Biography and Net Worth

James R. Jobe joined NHI as a director on April 29th, 2013. Mr. Jobe is an independent director. Mr. Jobe is a partner in the accounting firm of Jobe, Hastings & Associates, CPA’s, established in 1984 in Murfreesboro, Tennessee. In that capacity, he has provided accounting and consulting services in the healthcare and long-term care industries for over 27 years. Mr. Jobe previously served as an independent director of National Health Realty, Inc., a publicly-traded real estate investment trust, until its merger with National Healthcare Corporation in 2007. He received his Bachelor of Business Administration in Accounting from Middle Tennessee State University in 1984 and became a certified public accountant in 1986

What is James R. Jobe's net worth?: The estimated net worth of James R. Jobe is at least $1.26 million as of August 30th, 2023. Mr. Jobe owns 14,979 shares of National Health Investors stock worth more than $1,258,835 as of September 26th. This net worth evaluation does not reflect any other investments that Mr. Jobe may own. Learn More about James R. Jobe's net worth.
How do I contact James R. Jobe?: The corporate mailing address for Mr. Jobe and other National Health Investors executives is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. National Health Investors can also be reached via phone at (615) 890-9100 and via email at [email protected]. Learn More on James R. Jobe's contact information.
Has James R. Jobe been buying or selling shares of National Health Investors?: James R. Jobe has not been actively trading shares of National Health Investors within the last three months. Most recently, on Wednesday, August 30th, James R. Jobe bought 1,000 shares of National Health Investors stock. The stock was acquired at an average cost of $51.40 per share, with a total value of $51,400.00. Following the completion of the transaction, the director now directly owns 14,979 shares of the company's stock, valued at $769,920.60. Learn More on James R. Jobe's trading history.
Who are National Health Investors' active insiders?: National Health Investors' insider roster includes Robert Adams (Director), James Jobe (Director), Charlotte Swafford (Director), and Robert Webb (Director). Learn More on National Health Investors' active insiders.
Are insiders buying or selling shares of National Health Investors?: In the last year, National Health Investors insiders bought shares 2 times. They purchased a total of 10,437 shares worth more than $615,667.71. The most recent insider tranaction occured on May, 31st when Director Robert A Mccabe Jr bought 437 shares worth more than $28,767.71. Insiders at National Health Investors own 7.3% of the company. Learn More about insider trades at National Health Investors.
Information on this page was last updated on 5/31/2024.

James R. Jobe Insider Trading History at National Health Investors

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2023	Buy	1,000	$51.40	$51,400.00	14,979
9/24/2019	Sell	900	$83.23	$74,907.00	12,052
6/24/2014	Buy	1,000	$63.47	$63,470.00

James R. Jobe Buying and Selling Activity at National Health Investors

National Health Investors Company Overview

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Today's Range

Now: $84.04

$83.43

$85.22

50 Day Range

MA: $78.60

$72.10

$85.15

2 Week Range

Now: $84.04

$48.51

$86.13

Volume

203,237 shs

Average Volume

181,285 shs

Market Capitalization

$3.65 billion

P/E Ratio

27.55

Dividend Yield

4.25%

Beta

1.04

Don’t wait for FDA approval

From Weiss Ratings | Ad

Don’t let Wall Street fool you. AI is not the only hot sector in the market. Biotech is on fire as well.

And I’ll tell you all about them in this video.